ECMO - Extracorporeal Membrane Oxygenation Veno-Venous (VV) ECMO Management Questions and Answers

Question 1

A 45-year-old patient on VV ECMO for ARDS has shown significant radiological improvement and enhanced native lung gas exchange. The team plans to initiate a weaning trial. Which of the following is the most appropriate first step to assess the patient's readiness for liberation?

Accepted Answer

Gradually reduce the sweep gas flow rate while closely monitoring the patient's PaCO2.

Answer

The standard and safest initial step in weaning from VV ECMO is to gradually reduce the sweep gas flow. This allows the clinical team to assess the native lungs' ability to take over carbon dioxide clearance in a controlled manner. Abruptly stopping the sweep gas can cause rapid hypercapnia, and clamping the circuit is dangerous and risks thrombosis. Decreasing blood flow first would primarily impact oxygenation, while CO2 clearance is a more critical marker of lung recovery for weaning purposes.

Question 2

A patient on VV ECMO is receiving a continuous infusion of unfractionated heparin (UFH). Which laboratory test is considered the most specific for monitoring the therapeutic effect of heparin, especially in critically ill patients who may have underlying coagulopathies or heparin resistance?

Accepted Answer

Anti-Factor Xa (Anti-Xa) level

Answer

The Anti-Factor Xa (Anti-Xa) assay directly measures the ability of heparin to inhibit Factor Xa, providing a specific assessment of its anticoagulant effect. The aPTT can be influenced by numerous other factors common in critically ill patients (e.g., inflammation, factor deficiencies), making it less reliable. ACT is generally used for higher doses of heparin (like in cardiopulmonary bypass) and is less precise for therapeutic monitoring on ECMO. PT/INR monitors the extrinsic pathway, which is not the primary target of UFH.

Question 3

Which of the following best describes the primary goal of mechanical ventilation for a patient fully supported on VV ECMO for severe ARDS?

Accepted Answer

To promote lung rest and minimize ventilator-induced lung injury (VILI).

Answer

The fundamental purpose of using VV ECMO in ARDS is to allow the injured lungs to heal. This is achieved by using 'lung rest' or 'ultra-protective' ventilator settings. These settings involve low tidal volumes, low driving pressures (Plateau Pressure - PEEP), and low FiO2 to prevent further damage from mechanical stress (barotrauma, volutrauma) and oxygen toxicity. Since ECMO provides the majority of gas exchange, normalizing blood gases with aggressive ventilator settings is unnecessary and counterproductive.

Question 4

A patient on a stable femoro-jugular VV ECMO configuration for severe pneumonia develops acute hypoxemia (SpO2 drops from 95% to 86%). The ECMO circuit is functioning well, with a high post-oxygenator PaO2 and no signs of recirculation. Which patient-related factor is the most likely cause of this deterioration?

Accepted Answer

A sudden increase in the patient's native cardiac output.

Answer

In VV ECMO, the patient's arterial oxygenation is determined by the mixture of oxygenated blood from the ECMO circuit and the deoxygenated blood that passes through the native lungs (shunt). If the patient's cardiac output increases (due to fever, sepsis, agitation, etc.), a larger proportion of blood bypasses the ECMO circuit and goes through the diseased lungs. This larger shunt of deoxygenated blood mixes with the ECMO blood, resulting in a lower systemic arterial oxygen saturation. Oxygenator failure or cannula migration are circuit issues, and a decrease in sweep gas would primarily affect CO2 removal.

Question 5

During routine monitoring of a patient on VV ECMO, which of the following laboratory values is the most sensitive and direct indicator of circuit-induced red blood cell damage (hemolysis)?

Accepted Answer

Plasma-free hemoglobin (PFH)

Answer

Plasma-free hemoglobin (PFH) is a direct measurement of hemoglobin released into the plasma from damaged red blood cells, making it the most sensitive and specific marker for acute, intravascular hemolysis occurring within the ECMO circuit. While LDH will also be elevated and haptoglobin will be consumed (decrease), these markers are less specific and can be affected by other organ dysfunction. Bilirubin is a later, indirect marker of red cell breakdown.

ECMO - Extracorporeal Membrane Oxygenation Practice Test

ECMO - Extracorporeal Membrane Oxygenation Practice Test

ECMO - Extracorporeal Membrane Oxygenation Veno-Venous (VV) ECMO Management Questions and Answers